Trump, Ozempic
Digest more
The deal involves Eli Lilly, which makes Zepbound and Mounjaro, and Novo Nordisk, the maker of Ozempic and Wegovy. The drugs, known as GLP-1 medications, now cost as much as $1,350 a month. Under the agreement, eligible patients will pay around $245 to $350 per month, the administration said.
2don MSN
Ozempic Is About to Go on Sale
Even after Trump’s new deal, obesity drugs are still too expensive.
2don MSN
Trump punches new $35 billion hole in national debt with deal for Medicare to cover your Ozempic
Under the arrangement, prices for GLP-1 drugs—used both for diabetes and obesity—will be slashed for Medicare and Medicaid beneficiaries. The prices of Ozempic and Wegovy will fall from $1,000 and $1,
President Trump's plan drops the price of Ozempic and Wegovy for Americans, with plans for Medicare to cover the popular GLP-1 weight loss drugs.
This article was reviewed by Lynn Marie Morski, MD, JD. Does Ozempic® Cause Bone Loss? Key takeaways: Taking Ozempic® may cause some bone density loss, but
The Danish pharmaceutical giant Novo Nordisk has struck an agreement with the Centers for Medicare & Medicaid Services (CMS) to set a negotiated price for
Now the entire country knows (or at least believes) that Steven Cheung, 43, a longtime comms staffer and attackdog for Trump who once called Florida Governor Ron DeSantis a “desperate eunuch,” is on Ozempic.
A small study helps explain why some people taking Wegovy and similar weight-loss drugs cut back on alcohol, offering insight into potential new addiction therapies
Experts analyze whether Ozempic or the longevity diet offers safer, more effective weight loss while supporting long-term health and sustainability.
Novo Nordisk, as well as Eli Lilly, would gain Medicare and Medicaid coverage for their blockbuster weight-loss drugs.
Former child actress Amanda Bynes has shared a personal update with fans on social media. Bynes announced she's lost 20 pounds so far while taking Ozempic – and has a weight loss goal of 50 pounds, RadarOnline.com can reveal.
Jordan Klepper couldn’t help but notice that President Donald Trump was focused on odd things, like lowering the cost of Ozempic, instead of working to reopen the government as it entered its 37th day of the shutdown.